Towards an integral therapeutic protocol for breast cancer based upon the new H+-centered anticancer paradigm of the late post-warburg era

5Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

A brand new approach to the understanding of breast cancer (BC) is urgently needed. In this contribution, the etiology, pathogenesis, and treatment of this disease is approached from the new pH-centric anticancer paradigm. Only this unitarian perspective, based upon the hydrogen ion (H+) dynamics of cancer, allows for the understanding and integration of the many dualisms, confusions, and paradoxes of the disease. The new H+-related, wide-ranging model can embrace, from a unique perspective, the many aspects of the disease and, at the same time, therapeutically interfere with most, if not all, of the hallmarks of cancer known to date. The pH-related armamentarium available for the treatment of BC reviewed here may be beneficial for all types and stages of the disease. In this vein, we have attempted a megasynthesis of traditional and new knowledge in the different areas of breast cancer research and treatment based upon the wide-ranging approach afforded by the hydrogen ion dynamics of cancer. The concerted utilization of the pH-related drugs that are available nowadays for the treatment of breast cancer is advanced.

Cite

CITATION STYLE

APA

Harguindey, S., Alfarouk, K., Orozco, J. P., Fais, S., & Devesa, J. (2020, October 2). Towards an integral therapeutic protocol for breast cancer based upon the new H+-centered anticancer paradigm of the late post-warburg era. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms21207475

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free